Clinical Teams From Top Pharma Companies Are Overcoming Challenges in Planning and Implementing Adaptive Trial Design Studies
July 19, 2017 19:23 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - July 19, 2017) - A recent study of Top 10, Top 50, and small medical device companies found that addressing regulators' concerns for late-stage studies is...
Centralized Adaptive Trial Design Teams Facilitate Communication Between Global & Country-Level Pharma Teams
June 22, 2017 15:41 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - June 22, 2017) - The majority of surveyed clinical trial teams -- from those with global responsibility to those positioned at the country level -- report...
Adaptive Design Trials Emerge As Most Popular Method Used By Pharma Companies to Reduce Phase 3 Failures
June 07, 2017 16:27 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - June 07, 2017) - About 60% of surveyed life science teams believe that using adaptive design trials in early-stage clinical studies increase the odds of...
Study Finds Variations in Percentage of Clinical Teams Using Adaptive Trials and When
May 11, 2017 20:00 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - May 11, 2017) - There is no one-size-fits-all approach to strategic adaptive trial design use, according a study published by business intelligence firm...
Surveyed Top 50 Pharma and Biotech Companies Report Average Per-Patient Costs of $57,500 During Non-Adaptive Phase 1 Studies
March 27, 2017 19:28 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - March 27, 2017) - Surveyed pharmaceutical, biotech, and device companies expend up to $120,000 per patient during Phase 1 non-adaptive studies, according to...
Centralized Adaptive Trial Design Teams Promote Cross-Geography Communication
December 07, 2016 08:36 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - December 07, 2016) - A recent study released by Cutting Edge Information found that most surveyed clinical trial teams -- either global or at the country...
Risk-Based Monitoring: Pharma Doesn't Need to Reinvent the Wheel
November 03, 2014 05:00 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - November 03, 2014) - Encouraged by favorable FDA and EMA publications, a significantly increasing percentage of life sciences companies have begun...
Per-Patient Clinical Trial Costs Rise 70% in Three Years
July 14, 2011 10:02 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - Jul 14, 2011) - Per-patient clinical trial costs have risen an average 70 percent across all development phases since 2008, according to a new study by...
Patient Recruitment and Clinical Vendor Fees Top Trial Cost Drivers
June 22, 2011 09:23 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - Jun 22, 2011) - The highest clinical trial cost drivers are patient recruitment costs and vendor fees, according to a new study on clinical operations from...
Net-Present Value Still a Top Priority for Pharmaceutical In-Licensing Deals
June 21, 2011 09:52 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - Jun 21, 2011) - When evaluating a deal's potential profitability, pharmaceutical business development and licensing teams use similar criteria regardless of...